Erratum  by unknown
istered pre- and postconditioning has helped to re-
duce the incidence of mucositis associated with the
Bu/Cy/VP16 regimen.
Our institution’s experiences closely parallel the
results reported by Wadehra et al. and further validate
the toxicity and efﬁcacy proﬁle of this regimen. Post-
transplant survival was favorable, considering that this
population of patients was heavily pretreated, and half
of them had refractory disease at the time of trans-
plant. The low, 3% regimen-related 100-day mortal-
ity observed with this regimen, and the potential for
accurate patient-speciﬁc targeting of busulfan levels
offer the possibility that further dose escalation of
busulfan may be possible in the setting of autologous
stem cell transplantation.
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Erratum
In the article entitled “Human Progenitor Cells Rapidly Mobilized by AMD3100 Repopulate NOD/SCID
Mice with Increased Frequency in Comparison to Cells from the Same Donor Mobilized by Granulocyte
Colony Stimulating Factor” by Hess et al., in the April 2007 issue of Biology of Blood and Marrow
Transplantation (Volume 13, Number 4, pages 398-411), the third author’s name should have been Timothy
P. Craft (not Timothy C. Craft).
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